Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Otton

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
British Journal of Clinical Pharmacology|November 1, 1990
Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivityS V Otton, E M Gillam, M S Lennard, et al.
Pharmacogenetics|September 10, 1998
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and CaucasiansK Droll, K Bruce-Mensah, S V Otton, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Simultaneous gas chromatographic determination of methamphetamine, amphetamine and their p-hydroxylated metabolites in plasma and urineS Cheung, H Nolte, S V Otton, et al.
Clinical Pharmacology and Therapeutics|November 1, 1993
CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphoneS V Otton, M Schadel, S W Cheung, et al.
British Journal of Clinical Pharmacology|January 1, 1993
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadoneD Wu, S V Otton, B A Sproule, et al.
British Journal of Clinical Pharmacology|February 1, 1996
Venlafaxine oxidation in vitro is catalysed by CYP2D6S V Otton, S E Ball, S W Cheung, et al.
Behavioural Pharmacology|June 1, 1997
Effect of CYP2D1 inhibition on the behavioural effects of d-amphetamineD M Tomkins, S V Otton, N Joharchi, et al.
Journal of Clinical Psychopharmacology|April 1, 1997
CYP2D6 inhibition in patients treated with sertralineB A Sproule, S V Otton, S W Cheung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in ratsD M Tomkins, S V Otton, N Joharchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liabilityH L Kaplan, U E Busto, G J Baylon, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
British Journal of Clinical Pharmacology|November 1, 1990
Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivityS V Otton, E M Gillam, M S Lennard, et al.
Pharmacogenetics|September 10, 1998
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and CaucasiansK Droll, K Bruce-Mensah, S V Otton, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Simultaneous gas chromatographic determination of methamphetamine, amphetamine and their p-hydroxylated metabolites in plasma and urineS Cheung, H Nolte, S V Otton, et al.
Clinical Pharmacology and Therapeutics|November 1, 1993
CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphoneS V Otton, M Schadel, S W Cheung, et al.
British Journal of Clinical Pharmacology|January 1, 1993
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadoneD Wu, S V Otton, B A Sproule, et al.
British Journal of Clinical Pharmacology|February 1, 1996
Venlafaxine oxidation in vitro is catalysed by CYP2D6S V Otton, S E Ball, S W Cheung, et al.
Behavioural Pharmacology|June 1, 1997
Effect of CYP2D1 inhibition on the behavioural effects of d-amphetamineD M Tomkins, S V Otton, N Joharchi, et al.
Journal of Clinical Psychopharmacology|April 1, 1997
CYP2D6 inhibition in patients treated with sertralineB A Sproule, S V Otton, S W Cheung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in ratsD M Tomkins, S V Otton, N Joharchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liabilityH L Kaplan, U E Busto, G J Baylon, et al.
Pageof 4